摘要:
A steering device includes an outer column including fastening pieces formed to face each other at both sides, in the width direction, of a slot portion formed at either of a lower side or an upper side of an embracing body portion along an axial direction thereof, a fixed bracket clamping the outer column, a fastener that fastens the outer column and the fixed bracket, an inner column, and a pushing member having an expanding shaft portion. The two fastening pieces of the embracing body portion are connected by the fastener so that the two fastening pieces can be expanded and contracted, and the expanding shaft portion is elastically biased in an axial center direction of the outer column so as to abut on end zones of the slot portion and expand the two fastening pieces.
摘要:
The present invention relates to a compound represented by Formula [I]: or a pharmaceutically acceptable salt or ester thereof, wherein R1 and R2, which may be the same or different, are each a hydrogen atom, a lower alkyl group, a cycloalkyl group, or the like; R3 and R4, which may be the same or different, are each a hydrogen atom, a lower alkyl group, NRaRb, a phenyl group, a lower alkyl group substituted with a phenyl group, a 4- to 7-membered aliphatic heterocyclic group, a lower alkyl group substituted with a 4- to 7-membered aliphatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group, a lower alkyl group substituted with a 5- or 6-membered aromatic heterocyclic group, or the like; and R5 is a hydrogen atom, a cyano group, a halogen atom, or a lower alkyl group.
摘要翻译:本发明涉及由式[I]表示的化合物或其药学上可接受的盐或酯,其中R 1和R 2可以相同或不同,分别为氢原子,低级烷基,环烷基 ,等等; R 3和R 4可以相同或不同,分别为氢原子,低级烷基,NR a R b,苯基,被苯基取代的低级烷基,4-至7-元脂族杂环基, 被4-至7-元脂族杂环基取代的低级烷基,5或6元芳族杂环基,被5或6元芳族杂环基取代的低级烷基等; R5为氢原子,氰基,卤素原子或低级烷基。
摘要:
The present invention relates to a compound represented by Formula [I] or a pharmaceutically acceptable salt or ester thereof: wherein: X1, X2, X3, and X4, which may be identical or different, are each C or N, provided that none to two of X1, X2, X3, and X4 is/are N; Y is CH or N; R1, R1′, R2, R2′, R3, R3′, R4, and R4′, which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R5 is a hydrogen atom or a methyl group; R6 and R7, which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R8 and R8′, which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R9 is an aryl group or a heteroaryl group which may be substituted; and n is an integer from 1 to 3, and a PLK1 inhibitor or an anticancer agent containing the same.
摘要翻译:本发明涉及由式[I]表示的化合物或其药学上可接受的盐或酯:其中:X 1,X 2,X 3, / SUB>和X 4可以相同或不同,各自为C或N,条件是X 1,X 2, / SUB>,X 3和X 4是N; Y是CH或N; R 1,R 1,R 2,R 2,R 3,N 3, R 3,R 4,R 4,R 4和R 4可以相同或不同,分别为氢原子,低级 烷基等; R 5是氢原子或甲基; R 6和R 7可以相同或不同,分别为氢原子,低级烷基等; R 8和R 8可以相同或不同,分别为氢原子,低级烷基等; R 9是可以被取代的芳基或杂芳基; n为1〜3的整数,PLK1抑制剂或含有该PLK1抑制剂的抗癌剂。
摘要:
This invention relates to compounds represented by the general formula [I] wherein, R represents an azido group, etc., R1 and R2 are the same or different and represent hydrogen atoms, etc., R3 and R4 are the same or different and represent hydrogen atoms, etc., X1 represents an oxygen atom, etc., X2 represents an oxygen atom, etc., Y represents an oxygen atom, etc., and Z represents a condensed aryl group, etc., or a pharmaceutically acceptable salt thereof, preparation processes thereof, and an agent for treating diabetes, a prophylactic agent for chronic complications of diabetes or a drug against obesity, containing, as an effective ingredient, the compound or the pharmaceutically acceptable salt thereof.
摘要:
When molding of a heat-curable resin such as unsaturated polyester resin and the like is conducted by means of the casting method, concavities in the molded product generated as a result of the curing shrinkage of this resin are prevented. A central core member comprising ABS resin or the like is disposed in advance within mold, a heat-curable resin liquid is injected thereinto, and heated, and at this time, an amount of expansion in the volume of central core member is caused which corresponds to the amount of volume shrinkage resulting from curing of the heat-curable resin, and the expansion of the central core member is synchronized with the curing shrinkage of the heat-curable resin.
摘要:
A cosmetic composition comprising a silicone resin comprising from 50 to 99 mol % of R.sup.1 Si(O).sub.1.5 units wherein R.sup.1 represents a substituted or unsubstituted monovalent hydrocarbon group and from 1 to 50 mol % of (R.sup.2).sub.3 Si(O).sub.0.5 units wherein R.sup.2 represents a substituted or unsubstituted monovalent hydrocarbon group, sum of the R.sup.1 Si(O).sub.0.5 units and the (R.sup.2).sub.3 Si(O).sub.0.5 units being 100 mol %.
摘要:
The aqueous developing solution of the invention for positive-working photoresist compositions contains, in addition to an organic basic compound free from metallic ions, such as tetramethyl ammonium hydroxide and choline, as the principal ingredient, from 50 to 5000 ppm of an acetylene alcohol. In comparison with conventional developing solutions, the inventive developing solution is advantageous in the uniformity of the patterned photoresist layer, higher sensitivity and smaller temperature dependency of development and less drawbacks due to foaming of the solution.
摘要:
An electronic apparatus including a housing that includes a first connector, and a printed circuit board unit that includes a printed circuit board, a second connector that is connected to the first connector at the completion of insertion of the printed circuit board into the housing, a lever that is rotatably provided for the printed circuit board, and a lock mechanism that locks the lever in a predetermined position. Wherein when the printed circuit board is inserted into the housing, the lever in a first position comes into contact with the housing, when the printed circuit board is further inserted into the housing, the lever rotates in one direction while being in contact with the housing, and when the insertion of the printed circuit board into the housing is completed, the lever is in a second position, and the lock mechanism locks the lever in the second position.